Nvidia May be Back in Business in China. Here's What That Means for Revenue.

U.S. approval to export Nvidia's H200 to China and management's disclosure that H200s are licensed to many Chinese customers with orders and an imminent manufacturing ramp materially reopens a China sales channel (China was ~13% of FY2025 sales, roughly $28B). Nvidia previously took a $4.5B inventory charge when exports were halted; U.S. approval reportedly carries a condition to share 25% of China sales with the U.S. Near-term execution risk remains from restarting H200 production and competition from local Chinese chips, but the move represents meaningful company-specific upside and could meaningfully re-rate NVDA if volumes scale.

Analysis

Re-entry into a previously restricted market is a nonlinear growth event: the immediate lift will be concentrated in backlog conversion and system-configured sales rather than spot GPU unit volumes, so near-term revenue will skew toward high-margin hardware/software bundles. Expect a 2–6 month operational lag from permission to material shipments driven by packaging/test capacity, customs certification and channel re-onboarding — these bottlenecks create a clear front-loaded catalyst window that investors can time into.

Second-order competitive effects favor companies with entrenched software ecosystems and turnkey solutions more than pure-play silicon suppliers; buyers will trade off raw FLOPS for integrated stacks that reduce deployment time, which amplifies incumbents’ pricing power while giving local suppliers a slower but steady share-recapture pathway. Supply-chain winners will be outsourced assembly/test vendors and hyperscale integrators who can expand throughput quickly; losers will be players relying on spot GPU arbitrage or those with negligible software differentiation.

The biggest policy tail risk is reversibility: regulatory or political shifts can shutter access faster than commercial adoption can pivot, so real upside is path-dependent and asymmetric. Monitor three near-term catalysts that will telegraph real traction: recorded shipment volumes, product mix (systems vs cards) in subsequent quarterly disclosures, and any new export/license conditions — each will materially re-rate margin and cash-flow expectations over 1–4 quarters.

Key Decisions for Investors

• Long NVDA equity for 6–12 months (core position): accumulate on single-digit pullbacks and size to conviction. Hedge with 6-month protective puts ~15% OTM to cap downside from a policy reversal; reward is asymmetric if China ramps while hedge limits headline-policy drawdowns.
• Buy a 9–12 month NVDA call spread (bull-call) financed by selling nearer-dated calls: long 25–35% OTM call / short 5–6 month 50% OTM call. This reduces cost of carry while preserving meaningful upside through the initial China scale-up; lose if adoption stalls or policy reverses within months.
• Relative-value pair: long NVDA / short INTC (60/40 notional) for 3–12 months to express GPU-driven data-center share gains vs CPU incumbents. Risk: Intel execution or surprising product competitiveness; exit/trim on Intel beat + NVDA miss, or if regulatory headlines increase probability of export rollback.
• Event trade: buy NVDA near-term IV before the quarter when China shipment volumes are first disclosed (30–60 day straddle or long-dated calendar spread). Rationale: asymmetric IV skew ahead of a positive surprise; beware IV crush if disclosure is neutral — size small and define max loss.